Treatment of Chironomus polytene chromosomes with the ultimate carcinogen benzo[a]pyrene diol epoxide I or in vivo administration of the parent hydrocarbon to larvae indicates that the carcinogen interacts with the genome in a nonrandom manner. Visualization of the carcinogen-DNA binding sites by immunofluorescence reveals that, in vivo, some sites are preferentially modified. The combined effects of DNA sequence, chromatin structure, and gene localization may lead to selective targeting of carcinogens to specific genomic regions. In polytene chromosomes the targeting effect is amplified, thereby making these chromosomes a uniquely suitable system for visualizing and studying site-specific interactions of carcinogens with the genome.
The critical step in the interaction of a chemical carcinogen with the genome of a target cell, which may lead to transformation, is the formation of covalent carcinogen-DNA adducts. The generation of these adducts can be correlated with cellular mutation and transformation (1-3) and activation of cellular oncogenes (4, 5) . Since many ultimate carcinogens are mutagens (1) (2) (3) and since the activation of oncogenes is often associated with point mutations in the DNA sequence (6, 7) , it could be expected that, in a population of cells, the frequency of mutation should be approximately equal to the frequency of transformation. However, measurement of the frequencies of mutation and transformation revealed that in some cases the frequency of transformation was 10-1000 times higher than the frequency of mutation (3, 8, 9) . These results are especially puzzling because cellular transformation is a multistep process that may require activation of more than one gene (10) (11) (12) . The possibility that the high frequency of transformation is due to many target genes has been ruled out by experiments that revealed that, in several independently derived chemically transformed mouse cell lines, the same gene was responsible for transformation (13) .
The unexpected difference between the frequency of mutation and transformation could be explained by assuming that the binding of a carcinogen to DNA is not random and that, in fact, particular DNA sequences in the genome constitute preferential targets for carcinogen binding. Targeting of carcinogens to the DNA in the cell nucleus could be due to DNA sequence effects (14, 15) or to various nucleoprotein structures found in chromatin. Indeed, it has been reported that the linker DNA between adjacent core particles is more susceptible to carcinogen binding than the core particle DNA (16) (17) (18) (19) (20) and that transcribing genes are preferentially modified as compared to nontranscribing genes (14, 21) .
We previously have demonstrated that serological techniques can be used to study the distribution of the ultimate carcinogen benzo[a]pyrene diol epoxide I (BPDE-1) in both the cellular chromatin and in simian virus 40 minichromosomes (16, 22, 23) . In the present manuscript we use polytene chromosomes from Chironomus thummi to study the distribution of this carcinogen in the genome after both in vitro and in vivo exposures. Polytene chromosomes are giant interphase chromosomes active in transcription and replication, consisting of >1000 individual chromatids, which are precisely aligned. The size and structure of these chromosomes provide an excellent system for studying the effect of gene activity and chromatin structure on the distribution of a carcinogen in the genome. Furthermore over any particular region. This was most apparent at early reaction times, when very few molecules of the carcinogen were bound to the chromosomes (Fig. 1A) . Examination of highly modified chromosomes (Fig. 1B) in polytene chromosomes about 95% of the chromosomal mass resides in the bands (27) , it can be concluded that the binding is not strictly dependent on the chromosomal mass present in these regions. It is possible that the binding of the carcinogen is also dependent on the total surface area with which it can interact. Specific Binding to DNA Visualized by Immunofluorescence. The autoradiographic studies visualized the binding of the carcinogen to the proteins, RNA, and DNA of the chromosome. The binding to nucleic acids could be distinguished from the binding to proteins by using anti-BPDE-1-DNA antibodies in the indirect immunofluorescence technique. The antibodies used were those previously characterized by us (22, 23) and also preparations kindly provided by M. Poirier (28) . The sera do not react with proteins modified with BPDE-1 or with the ligand itself. Binding to RNA is eliminated by RNase digestion prior to antibody treatment (24) . The suitability of these antibodies for detecting carcinogenmodified regions in polytene chromosomes was further demonstrated by the fact that BPDE-1-treated chromosomes did not react with anti-BPDE-1 adsorbed on BPDE-1-DNA ( Fig. 2 A and B) and that untreated chromosomes did not react with anti-BPDE-1 ( Fig. 2 C and D) . Positive immunofluorescence was obtained only when BPDE-1-treated chromosomes were treated with specific antiserum (Fig. 2 E-H) .
Comparison of the fluorescence and phase-contrast pattern of these chromosomes showed that generally the fluorescence intensity was proportional to the density of the band observed under phase-contrast optics; however, the fluorescence intensity of the various regions depended on the concentration ofthe carcinogen and on the sera dilution used. At low carcinogen concentrations and high sera dilutions, the bands became more discrete, and differences in the intensity of fluorescence between various regions were obvious. We noted a particularly prominent band in region Bic/e of chromosome III (Fig. 2 G and H) quinacrine [a DNA-binding dye whose fluorescence is enhanced when bound to A-T and quenched when bound to G-C (31)] or mithramycin, which is a dye whose fluorescence is enhanced when bound to G-C (32) . The data presented in Fig.   4 indicate that region Blc/e of chromosome III is not disproportionately enriched in G-C sequences. The phasecontrast micrograph (Fig. 4A) shows that this region (open arrow) is puffed, as indicated by its wide, light, diffuse appearance. As noted by others (33, 34) , the centerofthe puff collapsed into a thin dark line. The immunofluorescence data (Fig. 4B) indicate that, when stained with anti-BPDE-1, this region fluoresced more brightly than the surrounding regions. Compared to other regions, the fluorescent band was not enriched in either A-T or C-G sequences (Fig. 4 C and D) .
The presence of a puff in region Bic/e of chromosome III suggests a possible correlation between the intensity of fluorescence with anti-BPDE-1 and chromosomal loci active in transcription. Loci active in transcription can be visualized in these chromosomes by autoradiography after incubating either the isolated salivary glands or isolated chromosomes with [3H]uridine (23, 25) . Photomicrographs (Fig. 5) indicate that the anti-BPDE-1 binding region Bic/e of chromsome III is also one of the most active in transcription. Generally, there was a correlation between the staining intensity and the density of autoradiographic grains. Interestingly, region A2a of chromosome III (hollow arrow) was active in transcription yet did not display prominent antibody binding. Examination of the phase-contrast micrographs shows that this region was relatively condensed, as evidenced by the diameter of the chromosome. Therefore, the binding ofthe carcinogen seems to be dependent on the chromatin decondensation associated with transcriptional processes rather than on the rate of transcription.
DISCUSSION
The results presented indicate that the binding in vivo of the ultimate carcinogen to the DNA in chromosomes is not random. Immunofluorescent data reveals variability in the level of modification among various loci in the chromosomes.
Region Bic/e of chromosome III, which is the most preferentially modified under in vitro conditions, is also the most highly BPDE-1-modified DNA region under in vivo conditions. The chromosomes were isolated from larvae that had been continuously exposed to benzo[a]pyrene. The presence ofthe adduct in a particular chromosomal region reflects both the tendency of a locus to be modified and the ability of the repair system to remove the adduct from that locus. Because region Bic/e of chromosome III is a preferentially modified locus under in vitro conditions, it would seem that the concentration of the adducts in this locus reflects its preferential modification rather than its resistance to repair.
Our data support previous experiments with cloned DNA fragments that indicated that carcinogens such as BPDE-1 or AFB1 can attack the DNA in a gene in a site-specific manner (14, 21) . Furthermore, the binding of the carcinogen to the DNA in chromatin is not random; the internucleosomal linker DNA is 3-5 times more accessible to modification than in the core-particle DNA (17) (18) (19) (20) 23) . The DNA in transcribing ribosomal regions seems to constitute a preferential target for carcinogen binding, suggesting that perturbation in chromatin structure associated with gene activity or compartmen-talization of active genes in the nucleus around nuclear matrixes (35) may significantly influence the manner in which the carcinogen binds to the genome. It may be significant that region Bic/e of chromosome III has a relatively high content of Z-DNA (36) . Thus, the data accumulated so far suggest that the combined effects of DNA sequence, chromatin structure, and gene localization in the nucleus may lead to selective targeting of carcinogens to specific genes. At the level of a single chromatid, these combined targeting effects may lead to a 4-to 10-fold preferential binding to a specific locus over random binding to the rest of the chromatid. Since in each chromatid the same locus is targeted over random binding to the rest of the genome, the targeting effect is amplified by the level of polyteny of the chromosome. Thus, in a polytene chromosome, the ratio of specific binding over random binding could be amplified as much as 1000-fold, thereby making the polytene chromosome a uniquely suitable system for analyzing and studying site-specific interactions of carcinogens with the genome.
